Meeting of the National Advisory Committee on Children and Disasters, 17267-17268 [2017-07052]
Download as PDF
17267
Federal Register / Vol. 82, No. 67 / Monday, April 10, 2017 / Notices
Secretary (OS), Department of Health
and Human Services, has submitted an
Information Collection Request (ICR),
described below, to the Office of
Management and Budget (OMB) for
review and approval. The ICR is for
renewal of the approved information
collection assigned OMB control
number 0990–0419, scheduled to expire
on June 30, 2017. Comments submitted
during the first public review of this ICR
will be provided to OMB. OMB will
accept further comments from the
public on this ICR during the review
and approval period.
DATES: Comments on the ICR must be
received on or before May 10, 2017.
ADDRESSES: Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 795–7714.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the OMB
control number 0990–0419 and
document identifier 0990–0419–30D for
reference.
Information Collection Request Title:
Acquisition Regulation Clause Patent
Rights and Rights and Data.
Abstract: The Department of Health
and Human Services; Office of the
Assistant.Secretary for Financial
Resources and Office of Grants and
Acquisition Policy and Accountability,
Division of Acquisition. is requesting an
approval by OMB for an extension of a
previously approved information
collection request, 0990–0419—
Acquisition Regulation Clause Patent
rights and Rights in Data. HHS found
that systematically, over a period of
several years, when Determination of
Exceptional Circumstances (DEC) were
executed, additional legal protection for
the patent and data rights of third
parties beyond those covered by FAR
27.306 were necessary A DEC is
executed consistent with the policy and
objectives of the Bayh-Dole Act, 35
Number of
responses per
respondent
Average
burden per
response
(hours)
Information
collection
Type of respondent and hours for each
(a) .....................
(b) .....................
(c) ......................
(d) .....................
(e) .....................
(f) ......................
(g) .....................
(h) .....................
(i) .......................
Technical (4), Legal (2), Management (2) .......................
Technical (8), Legal (2), Management (2) .......................
Technical (8), Legal (3), Management (1) .......................
Technical (8), Legal (4), Management (2) .......................
Technical (6), Legal (2), Management (2) .......................
Technical (4), Legal (2), Management (2) .......................
Administrative (8) ..............................................................
Administrative (2), Management (1) .................................
Technical (4), Legal (2), Management (2) .......................
63
63
63
63
63
63
63
63
63
1
1
3
3
1
1
3
3
3
8
12
12 (36)
14 (42)
10
8
8 (24)
3 (9)
8 (24)
504
756
2268
2646
630
504
1512
567
1512
Total ...........
...........................................................................................
63
19
83 (173)
10,899
Terry S. Clark,
Asst Information Collection Clearance
Officer.
[FR Doc. 2017–07143 Filed 4–7–17; 8:45 am]
BILLING CODE 4150–24–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Advisory
Committee on Children and Disasters
Office of the Secretary,
Department of Health and Human
Services.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
AGENCY:
ACTION:
Notice.
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the National Advisory Committee
on Children and Disasters (NACCD) will
SUMMARY:
VerDate Sep<11>2014
20:02 Apr 07, 2017
Jkt 241001
Number of
respondents
U.S.C. 200, et. seq., to ensure that
subject inventions made under contracts
and subcontracts (at all tiers) are used
in a manner to promote free competition
and enterprise without unduly
encumbering future research and
discovery; to encourage maximum
participation of small business firms in
federally supported research and
development efforts; to promote
collaboration between commercial
concerns and nonprofit organizations
including universities; to ensure that the
Government obtains sufficient rights in
federally supported inventions to meet
its needs; to protect the public against
nonuse or unreasonable use of
inventions; and in the case of fulfilling
the mission of the U.S. Department of
Health and Human Services, to
ultimately to benefit the public health.
Likely Respondents: Administrative,
technical, legal and management
personnel.
The total annual burden hours
estimated for this ICR are summarized
in the table below.
hold a public teleconference on May 5,
2017.
DATES: The NACCD meets May 5, 2017,
from 3:00 p.m. to 4:00 p.m. EST.
ADDRESSES: We encourage members of
the public to attend the teleconference.
To register, send an email under the
‘‘Contact Us’’ link on https://
www.phe.gov/naccd with ‘‘NACCD
Registration’’ in the subject line.
FOR FURTHER INFORMATION CONTACT: CDR
Evelyn Seel, MPH at (202) 205–7960.
Visit the NACCD Web site located at
https://www.phe.gov/naccd. Please
submit your comments on the NACCD
Contact Form located at https://
www.phe.gov/NACCDComments.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act
of 1972 (5 U.S.C., Appendix, as
amended), and section 2811A of the
Public Health Service Act (42 U.S.C.
300hh–10a), as added by section 103 of
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
Total
burden hours
the Pandemic and All-Hazards
Preparedness Reauthorization Act of
2013 (Pub. L. 113–5), the HHS
Secretary, in consultation with the
Secretary of the U.S. Department of
Homeland Security, established the
NACCD. The purpose of the NACCD is
to provide advice and consultation to
the HHS Secretary with respect to the
medical and public health needs of
children in relation to disasters.
Background: The NACCD public
teleconference on May 5, 2017, is
dedicated to the deliberation and vote
on two task letters from the Assistant
Secretary for Preparedness and
Response (ASPR). The first task letter
invites the NACCD to review the role of
the ASPR in future disaster
preparedness and response activities
that specifically affect the well-being of
children. The second task letter requests
the NACCD to assess progress and
remaining gaps in pediatric training
E:\FR\FM\10APN1.SGM
10APN1
17268
Federal Register / Vol. 82, No. 67 / Monday, April 10, 2017 / Notices
needs of professionals caring for
children in disasters since the 2011
National Center for Disaster Medicine
and Public Health Conference on this
topic. We will post modifications to the
agenda on the NACCD May 5, 2017
meeting Web page, which is located at
https://www.phe.gov/naccd.
Availability of Materials: We will post
all meeting materials prior to the
meeting on the NACCD May 5, 2017
meeting Web page located at https://
www.phe.gov/naccd.
Procedures for Providing Public Input:
Members of the public may attend the
teleconference using a toll-free call-in
phone number available on the NACCD
Web site at https://www.phe.gov/naccd.
We encourage members of the public to
provide written comments that are
relevant to the NACCD teleconference
prior to May 5, 2017. Send written
comments by email via the ‘‘Contact
Us’’ link on https://www.phe.gov/naccd
with ‘‘NACCD Public Comment’’ in the
subject line. The NACCD will respond
to comments received by close-ofbusiness April 28, 2017, during the
meeting.
Dated: April 4, 2017.
George W. Korch Jr.,
Acting Assistant Secretary for Preparedness
and Response.
[FR Doc. 2017–07052 Filed 4–7–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
patent applications listed below may be
obtained by communicating with the
indicated licensing contact Peter Soukas
at the Technology Transfer and
Intellectual Property Office, National
Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rockville,
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:02 Apr 07, 2017
Jkt 241001
MD 20852; tel. 301–496–2644. A signed
Confidential Disclosure Agreement will
be required to receive copies of
unpublished patent applications.
SUPPLEMENTARY INFORMATION:
Technology description follows.
A Full-Length Infectious cDNA Clone of
Zika Virus From the 2015 Epidemic in
Brazil as a Genetic Platform for Studies
of Virus-Host Interactions and Vaccine
Development
Description of Technology: An
arthropod-borne virus, Zika virus
(ZIKV), has recently emerged as a major
human pathogen. Associated with
complications during perinatal
´
development and Guillain-Barre
syndrome in adults, ZIKV raises new
challenges for understanding the
molecular determinants of flavivirus
pathogenesis. This underscores the
necessity for the development of a
reverse genetic system based on an
epidemic ZIKV strain. This technology
relates to the generation and
characterization in cell cultures of an
infectious cDNA clone of ZIKV isolated
from the 2015 epidemic in Brazil. The
cDNA-derived ZIKV replicated
efficiently in a variety of cell lines,
including those of both neuronal and
placental origin. It was observed that the
growth of cDNA-derived virus was
attenuated compared to the growth of
the parental isolate in most cell lines,
which correlates with substantial
differences in sequence heterogeneity
between these viruses that were
determined by deep-sequencing
analysis. Moreover, these results
indicate that caution should be
exercised when interpreting the results
of reverse-genetics experiments in
attempts to accurately predict the
biology of natural viruses. Finally, a
Vero cell-adapted cDNA clone of ZIKV
was generated that can be used as a
convenient platform for studies aimed at
the development of ZIKV vaccines (live
attenuated and inactivated) and
therapeutics.
This technology is available for
licensing nonexclusively in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
as well as for further development and
evaluation under a research
collaboration.
This technology is further described
in Tsetsarkin et al., ‘‘A Full-Length
Infectious cDNA Clone of Zika Virus
from the 2015 Epidemic in Brazil as a
Genetic Platform for Studies of VirusHost Interactions and Vaccine
Development,’’ mBio. 2016 Jul–Aug;
7(4): e01114–16. Published online 2016
Aug 23. doi: 10.1128/mBio.01114–16.
Potential Commercial Applications:
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
• Diagnostics
• Vaccines
• Development of therapeutics
Competitive Advantages:
• Use in development of flavivirus
vaccines
• Virus growth in various cell lines
• Developing and developed world
research tool
Development Stage:
• Research materials
Inventors: Alexander Pletnev (NIAID),
Konstantin Tsetsarkin (NIAID).
Intellectual Property: HHS Reference
No. E–114–2017/0.
Licensing Contact: Peter Soukas, J.D.,
301–594–8730; peter.soukas@nih.gov.
Collaborative Research Opportunity:
The National Institute of Allergy and
Infectious Diseases is seeking statements
of capability or interest from parties
interested in collaborative research to
further develop, evaluate or
commercialize vaccine(s) or diagnostics
for prophylaxis against flavivirus
infections. For collaboration
opportunities, please contact Peter
Soukas, J.D., 301–594–8730;
peter.soukas@nih.gov.
Dated: March 23, 2017.
Suzanne Frisbie,
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute
of Allergy and Infectious Diseases.
[FR Doc. 2017–07057 Filed 4–7–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by communicating
with the indicated licensing contact
James M. Robinson at the Technology
Transfer and Intellectual Property
Office, National Institute of Allergy and
SUMMARY:
E:\FR\FM\10APN1.SGM
10APN1
Agencies
[Federal Register Volume 82, Number 67 (Monday, April 10, 2017)]
[Notices]
[Pages 17267-17268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07052]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Advisory Committee on Children and
Disasters
AGENCY: Office of the Secretary, Department of Health and Human
Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the National Advisory Committee on Children and Disasters (NACCD)
will hold a public teleconference on May 5, 2017.
DATES: The NACCD meets May 5, 2017, from 3:00 p.m. to 4:00 p.m. EST.
ADDRESSES: We encourage members of the public to attend the
teleconference. To register, send an email under the ``Contact Us''
link on https://www.phe.gov/naccd with ``NACCD Registration'' in the
subject line.
FOR FURTHER INFORMATION CONTACT: CDR Evelyn Seel, MPH at (202) 205-
7960. Visit the NACCD Web site located at https://www.phe.gov/naccd.
Please submit your comments on the NACCD Contact Form located at
https://www.phe.gov/NACCDComments.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act of 1972 (5 U.S.C., Appendix, as amended), and section 2811A of the
Public Health Service Act (42 U.S.C. 300hh-10a), as added by section
103 of the Pandemic and All-Hazards Preparedness Reauthorization Act of
2013 (Pub. L. 113-5), the HHS Secretary, in consultation with the
Secretary of the U.S. Department of Homeland Security, established the
NACCD. The purpose of the NACCD is to provide advice and consultation
to the HHS Secretary with respect to the medical and public health
needs of children in relation to disasters.
Background: The NACCD public teleconference on May 5, 2017, is
dedicated to the deliberation and vote on two task letters from the
Assistant Secretary for Preparedness and Response (ASPR). The first
task letter invites the NACCD to review the role of the ASPR in future
disaster preparedness and response activities that specifically affect
the well-being of children. The second task letter requests the NACCD
to assess progress and remaining gaps in pediatric training
[[Page 17268]]
needs of professionals caring for children in disasters since the 2011
National Center for Disaster Medicine and Public Health Conference on
this topic. We will post modifications to the agenda on the NACCD May
5, 2017 meeting Web page, which is located at https://www.phe.gov/naccd.
Availability of Materials: We will post all meeting materials prior
to the meeting on the NACCD May 5, 2017 meeting Web page located at
https://www.phe.gov/naccd.
Procedures for Providing Public Input: Members of the public may
attend the teleconference using a toll-free call-in phone number
available on the NACCD Web site at https://www.phe.gov/naccd. We
encourage members of the public to provide written comments that are
relevant to the NACCD teleconference prior to May 5, 2017. Send written
comments by email via the ``Contact Us'' link on https://www.phe.gov/naccd with ``NACCD Public Comment'' in the subject line. The NACCD will
respond to comments received by close-of-business April 28, 2017,
during the meeting.
Dated: April 4, 2017.
George W. Korch Jr.,
Acting Assistant Secretary for Preparedness and Response.
[FR Doc. 2017-07052 Filed 4-7-17; 8:45 am]
BILLING CODE P